The histogenesis of this tumour is still unknown, despite immunohistochemestry and electron microscopy studies.
Epidemiology
Often occurs in the young adult, more frequently in females.
Clinics
Involve the musles and soft tissues of the lower extremities in adults (in more than half cases), the head and neck regions in the child, but it can also have extra muscular localizations, such as the female genital tract, the trunk, or the retroperitoneum; brain metastases are frequent.
Pathology
Secretory process with the formation of cytoplasmic crystals can be seen with electron microscopy.
Treatment
Aggressive surgical excision.
Prognosis
Relatively indolent clinical course. Overall survival of adult patients without metastases reaches 87% at 5 years, and that of adult patients with metastases is 20%, with a median survival of 40 months. Pediatric cases have a better prognosis, with a 5 years survival of 80% for all cases included, reaching 91% in cases without metastases.
Cytogenetics

Cytogenetics Morphological
der(X)t(X;17)(p11;q25) is consistently involved; it implicates: 1-the formation of a hybrid gene at the breakpoint, and also, 2-gain in Xp11-pter sequences, and loss of heterozygocity in 11q25-qter, with possible implications.
Genes involved and proteins
TFE3
Location Xp11 DNA / RNA 8 exons. Protein Transcription factor; member of the basic helix-loophelix family (b-HLH) of transcription factors primarily found to bind to the immunoglobulin enchancer muE3 motif.
ASPSCR1
Location 17q25 Protein 476 amino acids; contains an UBX domain.
